Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam vs Fentanyl with Bupivacaine for C-Section Spinal Block
NCT06917898Phase 1Active, not recruiting
- Sponsor
- Makassed General Hospital
- Start
- Apr 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of midazolam in postoperative pain (2 arms), sponsored by Makassed General Hospital. Primary endpoint: rescue analgesia at 24 Hours. Started Apr 2025; status: active, not recruiting.
02
Drugs
midazolam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06917898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06917898.